Talk:Deerfield Management

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

New York City Low‑importance

	New York City portal This article is within the scope of WikiProject New York City, a collaborative effort to improve the coverage of New York City-related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.New York CityWikipedia:WikiProject New York CityTemplate:WikiProject New York CityNew York City
Low	This article has been rated as Low-importance on the project's importance scale.

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Finance & Investment Low‑importance

	This article is within the scope of WikiProject Finance & Investment, a collaborative effort to improve the coverage of articles related to Finance and Investment on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Finance & InvestmentWikipedia:WikiProject Finance & InvestmentTemplate:WikiProject Finance & InvestmentFinance & Investment
Low	This article has been rated as Low-importance on the project's importance scale.

Private Equity

This article is within the scope of the WikiProject Private Equity, a collaborative effort to improve the depth of quality and coverage of the private equity and venture capital industry and related topics in Wikipedia. If you would like to participate, please visit the project page, where you can join the project and see a list of open tasks.

This project seeks to collaborate with the following WikiProjects:

Private EquityWikipedia:WikiProject Private EquityTemplate:WikiProject Private EquityPrivate Equity

Requested Edits July 2026

The user below has a request that an edit be made to Deerfield Management. That user has an actual or apparent conflict of interest.
The requested edits backlog is very high. Please be extremely patient. There are currently 637 requests waiting for review.

Please read the instructions for the parameters used by this template for accepting and declining them, and review the request below and make the edit if it is well sourced, neutral, and follows other Wikipedia guidelines and policies.

I would like to propose changes to improve the accuracy of information in this article. I have a WP:COI as an employee of Deerfield Management.

1. What I think should be changed:

In the History section, please replace the second and third sentences:

Change from:

In 2000, James Flynn joined Deerfield and would later become CEO of the firm.^[1]

In 2005, Snider formally retired from Deerfield.^[2]^[3]

Change to:

Snider formally retired from Deerfield in 2005. Subsequently James Flynn, who had joined the firm in 2000, became CEO.^[1]

Reason: The suggested rewrite removes a paid death announcement in the NYT (source 4) and a WSJ article (5) that doesn’t support any details in the sentence. The suggested replacement is verified entirely by the Institutional Investor article and places the events in chronological order.

2. What I think should be changed:

In the History section, please replace the sixth paragraph.

Change from:

In May 2019, Deerfield acquired 345 Park Avenue South which would become its new headquarters.^[4]

Change to:

In May 2019, Deerfield acquired 345 Park Avenue South in New York City to build Cure, a life sciences center, which would serve as the firm’s new headquarters.^[5]

Reason: Adding details about the building's purpose that are currently missing from the article.

3. What I think should be changed:

In the Notable deals section, please add as the second sentence of the first paragraph:

Deerfield later sold IMRIS to Grovecourt Capital Partners, a private equity firm, for an undisclosed amount.^[6]

Reason: The proposed sentence clarifies the status of Deerfield’s involvement with IMRIS. Currently the article notes that Deerfield acquired IMRIS, but not that it has since sold it. As written the page leaves readers with the impression that Deerfield continues to own or control the company.

4. What I think should be changed:

In the Notable deals section, please add to become the second sentence of the fifth paragraph:

Deerfield sold Melinta in 2025 to CorMedix for $300 million in cash and stock.^[7]

Reason: The proposed sentence clarifies the status of Deerfield’s involvement with Melinta Therapeutics. Currently the article notes that Deerfield acquired Melinta, but not that it has since sold it. As written the page leaves readers with the impression that Deerfield continues to own or control the company.

5. What I think should be changed:

After the Notable deals section, please create a new section section called “Research partnerships” and include the following as the first paragraph:

“Research partnerships”

In 2017, Deerfield began partnering with academic institutions to fund the further development of early-stage research.^[8] Deerfield founded Deerfield Discovery and Development (3DC) which has provided funding to academic centers including the Dana-Farber Cancer Institute, Johns Hopkins, and Stanford.^[9]

Reason: The suggested addition would add basic information about a significant area of the firm’s activities currently not covered in the article.

6. What I think should be changed:

Please move the third and fourth paragraphs of the Notable deals section into the “Research partnerships” subsection requested in item 6. I have made minor wording adjustments for clarity and grammar:

In October 2017, Deerfield committed $50 million to the Broad Institute to promote drug discovery.^[8]^[10]

In March 2019, Deerfield announced a partnership with Harvard University to fund the development of drugs and medical treatments. Deerfield committed up to $100 million to fund a new company, Lab1636.^[11]^[8]

Reason: The sentences describe examples of the firm’s research collaborations and are out-of-place in the Notable deals section, which describes transactions such as acquisitions and sales.

8. What I think should be changed:

Please change the title of the “Insider trading” section to “Controversies”

Reason: “Insider trading” is a non-standard section heading per WP:STYLE, whereas "Controversy" sections seem standard on highly-rated articles like Amazon (company), Tesla, Inc and Google. Additionally, as the article already notes, all of the charges of insider trading were eventually dismissed.

Thank you for reviewing.

1 2 "Deerfield Posts Another Double-Digit Gain in 2018". Institutional Investor. February 21, 2019. Retrieved April 8, 2023.
↑ Cite error: The named reference :1 was invoked but never defined (see the help page).
↑ Cite error: The named reference :0 was invoked but never defined (see the help page).
↑ "Deerfield Buying RFR's 345 Park Avenue South, Lining Up $525M in Debt". Commercial Observer. May 7, 2019. Retrieved April 8, 2023.
↑ Cunningham, Cathy (25 April 2022). "AIG Refinances Deerfield's 345 Park Avenue South With $440M Loan". Commercial Observer. Retrieved 8 June 2026. Deerfield purchased the building from Aby Rosen's RFR Holding in May 2019 for roughly $525 million, and utilizes a portion of the space as its headquarters today. The investment firm engaged Gensler to lead the property's redesign and conversion into a vertical life sciences campus, now known as CURE, comprising 11 floors of lab-ready space.
↑ Stempniak, Marty (20 February 2025). "Private-equity radiology group owner Grovecourt Capital acquires MRI solutions provider IMRIS Imaging". Radiology Business. Retrieved 8 June 2026.
↑ Kellaher, Colin (7 August 2025). "CorMedix to Buy Melinta Therapeutics for $300 Million". Wall Street Journal. Retrieved 8 June 2026. CorMedix has signed a deal to buy fellow biopharmaceutical company Melinta Therapeutics from healthcare-focused investment firm Deerfield Management for $300 million in cash and stock.
1 2 3 Gormley, Brian (January 9, 2019). "Biotech Investor Deerfield Is Financing Startups in University Labs". Wall Street Journal. ISSN 0099-9660. Retrieved April 8, 2023.
↑ Cross, Ryan (5 June 2024). "Former Sanofi R&D leader Frank Nestle to lead Deerfield's growing drug discovery arm". Endpoints News. Retrieved 8 June 2026.
↑ Rockoff, Jonathan D. (October 10, 2017). "Deerfield Management to Fund Biology Research at Broad Institute". Wall Street Journal. Retrieved April 8, 2023.
↑ "Deerfield, Harvard Team Up on Health Care Venture". Institutional Investor. March 13, 2019. Retrieved April 8, 2023.

[:2-1] 1 2 "Deerfield Posts Another Double-Digit Gain in 2018". Institutional Investor. February 21, 2019. Retrieved April 8, 2023.

[:1-2] Cite error: The named reference :1 was invoked but never defined (see the help page).

[:0-3] Cite error: The named reference :0 was invoked but never defined (see the help page).

[4] "Deerfield Buying RFR's 345 Park Avenue South, Lining Up $525M in Debt". Commercial Observer. May 7, 2019. Retrieved April 8, 2023.

[5] Cunningham, Cathy (25 April 2022). "AIG Refinances Deerfield's 345 Park Avenue South With $440M Loan". Commercial Observer. Retrieved 8 June 2026. Deerfield purchased the building from Aby Rosen's RFR Holding in May 2019 for roughly $525 million, and utilizes a portion of the space as its headquarters today. The investment firm engaged Gensler to lead the property's redesign and conversion into a vertical life sciences campus, now known as CURE, comprising 11 floors of lab-ready space.

[6] Stempniak, Marty (20 February 2025). "Private-equity radiology group owner Grovecourt Capital acquires MRI solutions provider IMRIS Imaging". Radiology Business. Retrieved 8 June 2026.

[7] Kellaher, Colin (7 August 2025). "CorMedix to Buy Melinta Therapeutics for $300 Million". Wall Street Journal. Retrieved 8 June 2026. CorMedix has signed a deal to buy fellow biopharmaceutical company Melinta Therapeutics from healthcare-focused investment firm Deerfield Management for $300 million in cash and stock.

[:6-8] 1 2 3 Gormley, Brian (January 9, 2019). "Biotech Investor Deerfield Is Financing Startups in University Labs". Wall Street Journal. ISSN 0099-9660. Retrieved April 8, 2023.

[9] Cross, Ryan (5 June 2024). "Former Sanofi R&D leader Frank Nestle to lead Deerfield's growing drug discovery arm". Endpoints News. Retrieved 8 June 2026.

[10] Rockoff, Jonathan D. (October 10, 2017). "Deerfield Management to Fund Biology Research at Broad Institute". Wall Street Journal. Retrieved April 8, 2023.

[:3-11] "Deerfield, Harvard Team Up on Health Care Venture". Institutional Investor. March 13, 2019. Retrieved April 8, 2023.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

This page was redesigned at the edge.

A page that knows where it met you.

Talk:Deerfield Management

Requested Edits July 2026